Published by Josh White on 8th March 2022
(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.
URL: http://www.digitallook.com/dl/news/story/32516079/...